We review progress with the receptor tyrosine kinases (growth factor receptors EGFR, VEGFR, and FGFR) and nonreceptor tyrosine kinases (Bcr - Abl), where advances have been made with
cancer therapeutic agents such as Herceptin and Gleevec.
After a successful postdoc at the Ontario Cancer Institute, where he developed a proprietary platform for the discovery of novel
cancer therapeutic agents, Bray was asked to join the former Amgen Research Institute in Toronto (now called the Advanced Medical Discovery Institute and no longer part of the parent company) as the head of their quantitative biology group and act as liaison to Amgen Inc. in California.
Not exact matches
A 1971 research report listed 14 references where chile was cited as a
therapeutic agent for
cancer.
Clinicians are currently worried that breast
cancer patients with low or absent BRCA1 may become resistant to
therapeutic agents such as Olaparib.
A new potential
therapeutic agent, diphenyleneiodonium chloride (DPI), effectively switches off
cancer stem cells, preventing their proliferation, researchers report.
The study, called «Molecular Determinants of Drug - Specific Sensitivity for Epidermal Growth Factor Receptor (EGFR) Exon 19 and 20 Mutants in Non-Small Cell Lung
Cancer,» and published online in the journal Oncotarget, demonstrates how computer modeling of EGFR mutations found in lung cancer can elucidate their molecular mechanism of action and consequently optimize the selection of therapeutic agents to treat pat
Cancer,» and published online in the journal Oncotarget, demonstrates how computer modeling of EGFR mutations found in lung
cancer can elucidate their molecular mechanism of action and consequently optimize the selection of therapeutic agents to treat pat
cancer can elucidate their molecular mechanism of action and consequently optimize the selection of
therapeutic agents to treat patients.
A team led by Fengzhi Li, PhD, and Xinjiang Wang, PhD, of Roswell Park
Cancer Institute (RPCI) has reported new findings regarding
therapeutic targets of the novel anticancer
agent FL118.
«New insights into the biology of heart failure are desperately needed to prompt new types of targeted
therapeutic agents,» says senior study author James Bradner of the Dana - Farber
Cancer Institute and Harvard Medical School.
The
cancer researchers also found that PAK is still active, when
cancer cells have already been treated with the current standard
therapeutic agent Imatinib.
The Vanderbilt findings provide «proof - of - concept that targeting an antitumor
agent to an intracellular protein may increase antitumor selectivity and improve the
therapeutic window for treating naturally occurring
cancers,» said first author Jashim Uddin, Ph.D., research associate professor of Biochemistry.
Southern Research has been awarded a new, five - year Indefinite - Delivery Indefinite - Quantity (IDIQ) contract from the National
Cancer Institute to investigate the pharmacokinetic properties of antitumor and other
therapeutic agents of interest -LSB-...]
It is unlikely that one Â
therapeutic agent will be able to target the
cancer stem cells in for example all types brain tumors.
Since the discovery that telomerase is repressed in most normal human somatic cells but strongly expressed in most human tumors, telomerase has become a target for
therapeutic agents to combat human
cancer.